Rubius Therapeutics, Inc.
USD0.06
+0.00 (+2.70%)
CEO
Laurence A. Turka
IPO Date
2018-07-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.06
Prev. Close
$0.06
Day Low
$0.06
Day High
$0.06
52W Low
$0.00
52W High
$0.38
Volume
0.76M
| 8,625 |
| $0.00 |
| 31 Jan 2023 | Turka Laurence A. | Chief Scientific Officer | M-Exempt | Acquired | 8,625 | $0.00 |
| 31 Jan 2023 | Turka Laurence A. | Chief Scientific Officer | S-Sale | Disposed | 2,593 | $0.24 |
| 31 Jan 2023 | Turka Laurence A. | Chief Scientific Officer | M-Exempt | Disposed | 7,438 | $0.00 |
| 31 Jan 2023 | Turka Laurence A. | Chief Scientific Officer | M-Exempt | Acquired | 7,438 | $0.00 |
| 31 Jan 2023 | CAGNONI PABLO J | director | M-Exempt | Acquired | 25,000 | $0.00 |
| 31 Jan 2023 | CAGNONI PABLO J | director | M-Exempt | Disposed | 25,000 | $0.00 |
| 31 Jan 2023 | CAGNONI PABLO J | director | S-Sale | Disposed | 7,240 | $0.24 |
| 31 Jan 2023 | CAGNONI PABLO J | director | M-Exempt | Acquired | 21,250 | $0.00 |